Microcap Trading at Cash Value, Inflecting Earnings, 15% Dividend Yield - Pharma-Bio Serv, Inc.
6 months ago
Elias’ Investing Journal
"PBSV: Microcap pharma consulting firm trading at net cash value with 15% dividend yield. Core business can earn $2M/yr (5x = $10M). Signs of recovery with European projects growing to 25% of rev (higher margin). Risks: CEO lacks ownership, customer concentration, tax grant ending 2024. 2x upside potential."
Sentiment
bullish
Conviction
Medium
Tier
Trade Call
Related Stocks
Episode Information
Episode:
Microcap Trading at Cash Value, Inflecting Earnings, 15% Dividend Yield - Pharma-Bio Serv, Inc.
Source:
Elias’ Investing Journal
Published:
June 12, 2025
Idea Type:
Stock Idea